Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ alpha E-Catenin/alpha N-Catenin Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA599602
Description
Antibody detects endogenous levels of total CTNNA1/CTNNA2.
This gene encodes a member of the catenin family of proteins that play an important role in cell adhesion process by connecting cadherins located on the plasma membrane to the actin filaments inside the cell. The encoded mechanosensing protein contains three vinculin homology domains and undergoes conformational changes in response to cytoskeletal tension, resulting in the reconfiguration of cadherin-actin filament connections. Certain mutations in this gene cause butterfly-shaped pigment dystrophy.
Specifications
alpha E-Catenin/alpha N-Catenin | |
Polyclonal | |
Unconjugated | |
CTNNA2 | |
Alpha E-catenin; Alpha N-catenin; alpha-catenin-related protein; alpha-E-catenin; alpha-N-catenin; Cadherin-associated protein; cadherin-associated protein, related; cancer/testis antigen 114; CAP102; CAPR; CAP-R; catenin (cadherin-associated protein), alpha 1, 102kDa; catenin (cadherin-associated protein), alpha 2; catenin alpha 1; catenin alpha 2; catenin alpha-1; Catenin alpha-2; CT114; CTNNA1; CTNNA2; CTNR; MDPT2; Renal carcinoma antigen NY-REN-13 | |
Rabbit | |
Affinity chromatography | |
RUO | |
1495, 1496 | |
-20°C | |
Liquid |
Western Blot, Immunocytochemistry | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
P26232, P35221 | |
CTNNA1, CTNNA2 | |
A synthesized peptide derived from human CTNNA1/CTNNA2, corresponding to a region within C-terminal amino acids. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction